Aardvark Therapeutics, Inc. (AARD)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 78
-0.08
-2.0725%
$
82.72M Market Cap
- P/E Ratio
- Div Yield
97,200 Volume
- Eps
$ 3.86
Previous Close 
Want to track AARD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aardvark Therapeutics, Inc. (AARD) Statistics
Valuation metrics
Market Cap 82.72M
Enterprise value 9.55M
Trailing P/E (ttm) -1.18
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) -
Price/Book (mrq) 1.1
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 159.9K
Average volume (90 days) 131.56K
Price summary
52-Week low 3.35
52-Week high 16.6
Beta -
50-Day moving average 5.15
200-Day moving average 5.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.86%
Return on equity -0.72%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.38
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 12.63%
Book value per share (mrq) 3.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
